Tratamiento farmacológico para la osteoporosis y su influencia en el proceso de consolidación de las fracturas

  1. Etxebarria, Íñigo
  2. Caeiro, José Ramón
  3. Larraínzar, Ricardo
  4. Vaquero, Eduardo
  5. Roca, Luis
  6. Mesa, Manuel
  7. Merino Pérez, Josu
  8. Carpintero, Pedro
  9. Fernández Cebrián, Antonio
  10. Hernáiz, Anna
Revista:
Revista de la Sociedad Andaluza de Traumatología y Ortopedia

ISSN: 1578-9756

Ano de publicación: 2016

Volume: 33

Número: 1

Páxinas: 21-38

Tipo: Artigo

Outras publicacións en: Revista de la Sociedad Andaluza de Traumatología y Ortopedia

Resumo

Osteoporotic fragility fractures can be seen as a major public health problem because their consequences in terms of mortality and morbidity. Taking into account the progressive ageing of the population and the increase in life expectancy, the expectative in the next future are not optimistic. They are and will be an important focus of health resources consumption. One of the strategies that have proven be effective for fracture prevention, is the antiosteoporotic pharmacological treatment. This type of treatments can affect bone healing process in one way or another. In this review, based on the current scientific evidence, we want to establish how each one of the drugs prescribed for the osteoporosis treatment affects the bone healing process of fragility fractures, an issue that generates doubts and uncertainties in the orthopaedic surgeon, whom responsibility and role in fracture prevention is essential